Latest News and Press Releases

CAMBRIDGE, United Kingdom, Dec. 02, 2004 (PRIMEZONE) -- * Astex Technology, the fragment-based drug discovery and development company, received the Research and Development Award ...

CAMBRIDGE, U.K., Oct. 25, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery and development company, today announced that it has completed a significant goal in its multi-target...

CAMBRIDGE, U.K., Oct. 11, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery and development company, today announced the appointment of Dr Martin Buckland as Senior Vice...

CAMBRIDGE, United Kingdom, Oct. 5, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, is again ranked as the fastest growing biotechnology company in the Sunday Times...

CAMBRIDGE, United Kingdom, July 16, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery and development company, today announced that its scientists had published the...

CAMBRIDGE, U.K., June 8, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery and development company, today announced that it has extended its existing structural biology research...

CAMBRIDGE, U.K., April 19, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced that it has received the second milestone payment from AstraZeneca as part...

CAMBRIDGE, U.K., March 22, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, together with The Wellcome Trust, the Institute of Cancer Research and Cancer Research...

CAMBRIDGE, U.K., March 9, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced a three year, multi-target-based, alliance with Boehringer Ingelheim for the...

CAMBRIDGE, U.K., Nov. 12, 2003 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced the appointment of Dr John Lyons as Director of Oncology. Dr Lyons will...